Search Results 251-260 of 16307 for nivolumab

  1. Stage 4 (Metastatic) Colon Cancer Clinical Trials - Mayo Clinic Research

    ... nivolumab and ipilimumab, in patients with metastatic non-small cell lung cancer, microsatellite stable colorectal cancer, gastroesophageal adenocarcinoma ...

  2. ICI And Response In Autoimmunity - Mayo Clinic

    ... nivolumab, cemiplimab, atezolimumab, durvalumab, or avelumab. Presence of inflammatory arthritis defined by: Provider documents inflammatory arthritis in one ...

  3. Phase 1b Open-Label Study of PEGPH20 With Pembrolizumab - Mayo Clinic

    Previous treatment with pembrolizumab, nivolumab, or other programmed cell death-1 antibody (anti- PD-1) or PD-1 ligand-antibody (anti-PD-L1) agents. New ...

  4. Publications - Konstantinos Leventakos, M.D., Ph.D. - Mayo Clinic

    2017; 12: (1)e0170626. View PubMed; Leventakos K, Mansfield AS. Advances in the Treatment of Non-small Cell Lung Cancer: Focus on Nivolumab, Pembrolizumab, and ...

  5. Small Cell Lung Cancer Clinical Trials

    This a Phase 1 study designed to determine the maximum tolerated dose (MTD) and toxicity of attenuated Measles virus (MV-NIS) combined with nivolumab in ...

  6. Drugs and Supplements that Start with N - Mayo Clinic

    Nivolumab and hyaluronidase-nvhy (subcutaneous route) · Nivolumab/relatlimab-rmbw (intravenous route). Nix. Also known as. Permethrin (topical route). Nix ...

  7. Drugs and Supplements that Start with O - Mayo Clinic

    Nivolumab and hyaluronidase-nvhy (subcutaneous route). Opdualag. Also known as. Nivolumab/relatlimab-rmbw (intravenous route). Operand Chg Surgical Scrub ...

  8. Cancer News - Medical Professionals - Mayo Clinic

    Medical Professionals news and the latest information about Cancer.

  9. Circulating Tumor Nucleic Acids to Monitor Treatment Response in Metastatic Melanoma Patients - Mayo Clinic

    About this study. This project will investigate whether the analysis of nucleic acids circulating in the blood from tumors can allow real-time monitoring of ...

  10. Dendritic Cell Therapy After Cryosurgery in Combination With Pembrolizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Remove by Surgery - Mayo Clinic

    Lack of response to therapy with a PD-1- or PD-L1-targeting monoclonal antibody (pembrolizumab, nivolumab, etc.) after at least 18 weeks of therapy OR ...